Reuters logo
BRIEF-Health Canada approves Novo Nordisk's Tresiba, a new basal insulin for type 1 and 2 diabetes
August 28, 2017 / 12:47 PM / a month ago

BRIEF-Health Canada approves Novo Nordisk's Tresiba, a new basal insulin for type 1 and 2 diabetes

Aug 28 (Reuters) - Novo Nordisk A/S

* Health Canada approves Tresiba®, a new basal insulin for type 1 and 2 diabetes

* ‍Novo Nordisk Canada Inc - Health Canada has approved Tresiba​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below